Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

As European markets face a downturn, with the pan-European STOXX Europe 600 Index ending the week down 2.54% amid geopolitical tensions and economic uncertainties, investors are increasingly looking towards growth companies with significant insider ownership as potential opportunities. In this environment, stocks that combine robust growth prospects with high levels of insider investment can offer a compelling mix of confidence and alignment between company leadership and shareholders.

Top 10 Growth Companies With High Insider Ownership In Europe

Name Insider Ownership Earnings Growth Magnora (OB:MGN) 10.4% 94.4% Hacksaw (OM:HACK) 13.2% 21.5% Envipco Holding (ENXTAM:ENVI) 19.5% 46.4% Elliptic Laboratories (OB:ELABS) 19.8% 124.9% Egetis Therapeutics (OM:EGTX) 11.3% 91.9% CTT Systems (OM:CTT) 17.4% 45.3% Clavister Holding AB (publ.) (OM:CLAV) 18% 116.2% Circus (XTRA:CA1) 21.9% 88% Bonesupport Holding (OM:BONEX) 10.3% 34.5% Bergen Carbon Solutions (OB:BCS) 10.2% 55.5%

Click here to see the full list of 212 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Sdiptech

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sdiptech AB (publ) offers technical services for infrastructures across multiple countries, including Sweden, the UK, and the US, with a market cap of SEK8.56 billion.

Operations: Revenue segments (in millions of SEK): null

Insider Ownership: 11.6%

Sdiptech, with significant insider ownership, is poised for growth despite recent challenges. The company's Q1 2026 earnings showed a decline in net income to SEK 14 million from SEK 71 million the previous year. However, analysts forecast a robust annual earnings growth of 62.75%, outpacing the Swedish market's revenue growth rate of 0.4%. While trading at a substantial discount to fair value, Sdiptech's financial position requires attention due to insufficient interest coverage by earnings.

Click here to discover the nuances of Sdiptech with our detailed analytical future growth report. In light of our recent valuation report, it seems possible that Sdiptech is trading behind its estimated value.OM:SDIP B Ownership Breakdown as at Apr 2026

Redcare Pharmacy

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €963.34 million.

Operations: The company generates revenue from its DACH segment amounting to €2.40 billion and from its International segment totaling €540 million.

Insider Ownership: 13.7%

Story Continues

Redcare Pharmacy, with high insider ownership, is experiencing strong growth prospects despite recent financial challenges. The company's Q1 2026 revenue rose to €848 million, up 18.3% year-over-year, driven by non-Rx growth in Germany and Rx momentum in Germany and Switzerland. Although it reported a net loss of €37.7 million for 2025, Redcare's earnings are forecast to grow significantly at 53.19% annually and become profitable within three years, outperforming the German market's revenue growth rate.

Click to explore a detailed breakdown of our findings in Redcare Pharmacy's earnings growth report. Our valuation report here indicates Redcare Pharmacy may be undervalued.XTRA:RDC Ownership Breakdown as at Apr 2026

Stratec

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Stratec SE, with a market cap of €214.19 million, provides automation solutions for in-vitro diagnostics and life science companies across Germany, the European Union, and internationally.

Operations: The company's revenue segments include automation solutions for in-vitro diagnostics and life science companies, serving clients in Germany, the European Union, and internationally.

Insider Ownership: 30.9%

Stratec, with significant insider ownership, is poised for growth despite recent setbacks. The company reported a net loss of €0.24 million in 2025 compared to a net income of €16.02 million the previous year, but earnings are forecast to grow at 35.29% annually and become profitable within three years, outperforming the German market's revenue growth rate of 6.1%. However, its dividend yield of 3.41% isn't well covered by free cash flows.

Take a closer look at Stratec's potential here in our earnings growth report. Our expertly prepared valuation report Stratec implies its share price may be too high.XTRA:SBS Earnings and Revenue Growth as at Apr 2026

Next Steps

Dive into all 212 of the Fast Growing European Companies With High Insider Ownership we have identified here. Contemplating Other Strategies? We've found 15 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:SDIP B XTRA:RDC and XTRA:SBS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

View Comments